Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
31.3M
-
Number of holders
-
227
-
Total 13F shares, excl. options
-
35.9M
-
Shares change
-
+562K
-
Total reported value, excl. options
-
$3.73B
-
Value change
-
+$69.7M
-
Put/Call ratio
-
3.3
-
Number of buys
-
119
-
Number of sells
-
-104
-
Price
-
$103.86
Significant Holders of CONMED Corp - Common Stock (CNMD) as of Q1 2023
271 filings reported holding CNMD - CONMED Corp - Common Stock as of Q1 2023.
CONMED Corp - Common Stock (CNMD) has 227 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 35.9M shares
.
Largest 10 shareholders include BlackRock Inc. (4.92M shares), VANGUARD GROUP INC (3.45M shares), EARNEST PARTNERS LLC (2.72M shares), Capital Research Global Investors (2.4M shares), AMERIPRISE FINANCIAL INC (1.35M shares), STATE STREET CORP (1.17M shares), BANK OF AMERICA CORP /DE/ (1.13M shares), JPMORGAN CHASE & CO (1.02M shares), Champlain Investment Partners, LLC (984K shares), and LOOMIS SAYLES & CO L P (803K shares).
This table shows the top 227 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.